Chainitikun S, Long JP, Rodriguez-Bautista R, Iwase T, et al. The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Breast Cancer Res Treat 2020 Jul 27. pii: 10.1007/s10549-020-05837.
PMID: 32720114